ArticleMolecular cancer therapeutics2016

Plasma Metabolomic Changes following PI3K Inhibition as Pharmacodynamic Biomarkers: Preclinical Discovery to Phase I Trial Evaluation.

Joo Ern Ang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.